Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ)
CNY 23.75
(-0.88%)
CNY 23.75
(-0.88%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 351.4 Million CNY | -12.14% |
| 2022 | 399.96 Million CNY | 3.55% |
| 2021 | 386.24 Million CNY | 2.54% |
| 2020 | 376.66 Million CNY | 68.46% |
| 2019 | 223.59 Million CNY | 34.93% |
| 2018 | 165.71 Million CNY | 26.86% |
| 2017 | 130.62 Million CNY | 64.75% |
| 2016 | 79.29 Million CNY | 61.97% |
| 2015 | 48.95 Million CNY | -4.84% |
| 2014 | 51.44 Million CNY | 13.7% |
| 2013 | 45.24 Million CNY | 10.76% |
| 2012 | 40.84 Million CNY | -15.18% |
| 2011 | 48.15 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 390.92 Million CNY | -5.2% |
| 2024 Q1 | 346.88 Million CNY | -1.28% |
| 2024 Q2 | 412.38 Million CNY | 18.88% |
| 2023 Q3 | 381.73 Million CNY | -8.18% |
| 2023 Q1 | 466.7 Million CNY | 16.69% |
| 2023 Q2 | 415.73 Million CNY | -10.92% |
| 2023 FY | 351.4 Million CNY | -12.14% |
| 2023 Q4 | 351.4 Million CNY | -7.95% |
| 2022 Q3 | 574.69 Million CNY | -7.99% |
| 2022 FY | 399.96 Million CNY | 3.55% |
| 2022 Q2 | 624.62 Million CNY | -17.64% |
| 2022 Q1 | 758.36 Million CNY | 96.35% |
| 2022 Q4 | 399.96 Million CNY | -30.4% |
| 2021 Q1 | 435.24 Million CNY | 15.55% |
| 2021 FY | 386.24 Million CNY | 2.54% |
| 2021 Q3 | 467.09 Million CNY | -6.19% |
| 2021 Q2 | 497.94 Million CNY | 14.4% |
| 2021 Q4 | 386.24 Million CNY | -17.31% |
| 2020 Q1 | 291.26 Million CNY | 30.26% |
| 2020 Q3 | 271.56 Million CNY | -11.77% |
| 2020 Q4 | 376.66 Million CNY | 38.7% |
| 2020 FY | 376.66 Million CNY | 68.46% |
| 2020 Q2 | 307.78 Million CNY | 5.67% |
| 2019 Q1 | 180.93 Million CNY | 9.19% |
| 2019 FY | 223.59 Million CNY | 34.93% |
| 2019 Q4 | 223.59 Million CNY | -14.37% |
| 2019 Q2 | 244.41 Million CNY | 35.09% |
| 2019 Q3 | 261.1 Million CNY | 6.83% |
| 2018 Q4 | 165.71 Million CNY | -12.16% |
| 2018 Q2 | 178.41 Million CNY | 22.4% |
| 2018 Q1 | 145.76 Million CNY | 11.59% |
| 2018 FY | 165.71 Million CNY | 26.86% |
| 2018 Q3 | 188.64 Million CNY | 5.74% |
| 2017 Q1 | 86.29 Million CNY | 8.83% |
| 2017 FY | 130.62 Million CNY | 64.75% |
| 2017 Q4 | 130.62 Million CNY | -15.65% |
| 2017 Q3 | 154.86 Million CNY | 33.8% |
| 2017 Q2 | 115.73 Million CNY | 34.12% |
| 2016 FY | 79.29 Million CNY | 61.97% |
| 2016 Q3 | 68.01 Million CNY | 28.82% |
| 2016 Q2 | 52.79 Million CNY | 2.98% |
| 2016 Q1 | 51.26 Million CNY | 4.73% |
| 2016 Q4 | 79.29 Million CNY | 16.59% |
| 2015 Q2 | 46.03 Million CNY | -4.06% |
| 2015 FY | 48.95 Million CNY | -4.84% |
| 2015 Q3 | 49.6 Million CNY | 7.75% |
| 2015 Q4 | 48.95 Million CNY | -1.32% |
| 2015 Q1 | 47.98 Million CNY | -6.71% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 51.44 Million CNY | 0.0% |
| 2014 FY | 51.44 Million CNY | 13.7% |
| 2013 FY | 45.24 Million CNY | 10.76% |
| 2012 FY | 40.84 Million CNY | -15.18% |
| 2011 FY | 48.15 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 76.712% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -1401.861% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | 38.667% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | -52.953% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | -35.671% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 61.278% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -252.961% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | 41.645% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -1120.876% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | 4.435% |